Clinical trial NCT06201195: Anterior Cutaneus Nerve and Distal Adductor Canal Block With USG for Total Knee Replacement Analgesia
Official title: Contribution of Anterior Femoral Cutaneous Nerve Block to Postoperative Analgesia for Total Knee Replacement
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Pain Measurement
Knee Replacement Arthroplasty
Nerve Block
Keywords: anterior femoral cutaneus nerve block
distal adductor canal block
total knee arthroplasthy
Lead sponsor: Diskapi Teaching and Research Hospital
Sponsor class: OTHER
First posted: 2024-01-11
Enrollment: 58
Sex: ALL
Minimum age (years): 40
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: The goal of this clinical trial is to compare analhesia effects of adductor canal blockade versus distal adductur canal blockade added anterior cutaneus nerve block in total knee arthroplasty.

The main questions it aims to answer are:

* question 1: does distal adductor canal blockade + anterior cutaneus nerve blokade superior analgesia then adductor canal block for undergoing TKP?
* question 2: does distal adductor canal blockade + anterior cutaneus nerve blokade decrease drain place pain on anterolateral face of knee?

Detailed description: Patients with American Society of Anesthesiologists classification status I-III scheduled for elective primary TKA using standard spinal anesthesia enroll for this trial. After surgery patient divided two groups: 1- adductor canal blockade 2- distal adductor canal blockade + anterior femoral cutaneus nerve blockade. At postoperative 3th, 10th, 24th hour VAS (visuel analouge scale), VAS move, incision plase pain-for top and down of patella, drain place pain, motor strenght for femoral nerve and siyatic nerve, first analjesic requirement time, opioid consumption, total analcesic requirement will be recorded.

Eligibility criteria: Inclusion Criteria:

* Total knee artroplasty
* Spinal anesthesia
* ASA 1-3

Exclusion Criteria:

* Bupivacaine allergy
* Coagulopathy
* Infection on injection site

Primary outcomes:
measure: VAS (visuel analouge scale)
timeFrame: postblock 3 hour,10 hour, 24 hour
measure: drain place pain
timeFrame: postblock 3 hour,10 hour, 24 hour
Secondary outcomes:
measure: VAS movement
timeFrame: postblock 3 hour,10 hour, 24 hour
measure: motor strenght
timeFrame: postblock 3 hour,10 hour, 24 hour
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Ankara Etlik City Hospital
Study officials:
affiliation: Study Principal Investigator Ankara Etlik City Hospital
name: Derya Ozkan
role: STUDY_DIRECTOR
affiliation: Study Principal Investigator Ankara Etlik City Hospital
name: Müge Çakırca, doctor
role: PRINCIPAL_INVESTIGATOR
affiliation: Study Principal Investigator Ankara Etlik City Hospital
name: Funda Atar, doctor
role: STUDY_CHAIR
affiliation: Study Principal Investigator Ankara Etlik City Hospital
name: Serhan ünlü, doctor
role: STUDY_CHAIR
References:
citation: Bjorn S, Nielsen TD, Moriggl B, Hoermann R, Bendtsen TF. Anesthesia of the anterior femoral cutaneous nerves for total knee arthroplasty incision: randomized volunteer trial. Reg Anesth Pain Med. 2019 Dec 10:rapm-2019-100904. doi: 10.1136/rapm-2019-100904. Online ahead of print.